Navigation Links
Cedars-Sinai physician definitively links irritable bowel syndrome and bacteria in gut
Date:5/25/2012

LOS ANGELES (May 25, 2012) An overgrowth of bacteria in the gut has been definitively linked to Irritable Bowel Syndrome in the results of a new Cedars-Sinai study which used cultures from the small intestine. This is the first study to use this "gold standard" method of connecting bacteria to the cause of the disease that affects an estimated 30 million people in the United States.

Previous studies have indicated that bacteria play a role in the disease, including breath tests detecting methane a byproduct of bacterial fermentation in the gut. This study was the first to make the link using bacterial cultures.

The study, in the current issue of Digestive Diseases and Sciences, examined samples of patients' small bowel cultures to confirm the presence of small intestinal bacterial overgrowth or SIBO in more than 320 subjects. In patients with IBS, more than a third also were diagnosed with small intestine bacterial overgrowth, compared to fewer than 10 percent of those without the disorder. Of those with diarrhea-predominant IBS, 60 percent also had bacterial overgrowth.

"While we found compelling evidence in the past that bacterial overgrowth is a contributing cause of IBS, making this link through bacterial cultures is the gold standard of diagnosis," said Mark Pimentel, MD, director of the Cedars-Sinai GI Motility Program and an author of the study. "This clear evidence of the role bacteria play in the disease underscores our clinical trial findings, which show that antibiotics are a successful treatment for IBS."

IBS is the most common gastrointestinal disorder in the U.S., affecting an estimated 30 million people. Patients with this condition suffer symptoms that can include painful bloating, constipation, diarrhea or an alternating pattern of both. Many patients try to avoid social interactions because they are embarrassed by their symptoms. Pimentel has led clinical trials that have shown rifaximin, a targeted antibiotic absorbed only in the gut, is an effective treatment for patients with IBS.

"In the past, treatments for IBS have always focused on trying to alleviate the symptoms," said Pimentel, who first bucked standard medical thought more than a decade ago when he suggested bacteria played a significant role in the disease. "Patients who take rifaximin experience relief of their symptoms even after they stop taking the medication. This new study confirms what our findings with the antibiotic and our previous studies always led us to believe: Bacteria are key contributors to the cause of IBS."


'/>"/>
Contact: Nicole White
nicole.white@cshs.org
310-423-5215
Cedars-Sinai Medical Center
Source:Eurekalert

Related medicine news :

1. Cedars-Sinai stroke team earns award for improving regions quality of care
2. American College of Cardiology honors 2 Cedars-Sinai Heart Institute physicians
3. Cedars-Sinai awarded $2.5 million to study potential new drug treatments for Alzheimers disease
4. Moderate red wine drinking may help cut womens breast cancer risk, Cedars-Sinai study shows
5. Cedars-Sinai study: How does a good protein hurt brain cells after clot-induced stroke?
6. TGen and Virginia G. Piper Cancer Center form drug development collaboration with Cedars-Sinai
7. Cedars-Sinai scientists, physicians to be key presenters at World Stem Cell Summit
8. Cedars-Sinai movement disorders expert on international task force for dystonia treatment
9. Latest data from Cedars-Sinai vaccine study supports immune targeting of brain tumors
10. Cedars-Sinais mobile medical clinics receive $500,000 grant from California Community Foundation
11. Cedars-Sinai to hold first annual conference on stem cell therapies for neurological disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2020)... ... September 03, 2020 , ... ... will be the focus of Fall 2020 Virtual Conference, a two-day virtual event ... "AI, Enterprise Imaging & Beyond" is the follow-up to AuntMinnie.com's successful virtual event ...
(Date:9/3/2020)... BOSTON (PRWEB) , ... September 03, 2020 , ... ... Seal of Approval for Sunrise Technologies WALI wireless parking lot controller. This advanced ... for minimizing glare, reducing light trespass, and protecting the night sky against light ...
(Date:9/1/2020)... ... September 01, 2020 , ... KitoTech ... million convertible note financing, which will be used to accelerate the commercialization of ... this financing, the company will continue to expand its customer base of healthcare ...
(Date:9/1/2020)... ... September 01, 2020 , ... Dr. Kiran Gill ... aesthetic surgery of the face, breast, and body. In 2018, she founded Aesthetics ... plastic surgery and aesthetic practice in Southwest Florida. Dr. Gill and her team ...
(Date:8/31/2020)... ... 2020 , ... Just found out your dear friend has cancer? , It’s hard to hear ... member shares their diagnosis. Once the shock wears off, the questions and fears can be ... the best ways to help? Words are failing me. I’m scared. I want to DO ...
Breaking Medicine News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... Breast and ovarian cancers are common diseases that ... of breast cancers (about 7,500 women per year) and 10% of ovarian cancers (about ... Both genes are detectable in the Women’s Excellence Genetic Testing Program. , Dr. ...
(Date:8/31/2020)... ... August 31, 2020 , ... Cloudticity ... has named Cloudticity a Gold winner in the 15th Annual 2020 Network PG’s ... o ns from Network Products Guide honoring achievements of world’s best ...
(Date:8/27/2020)... ... August 27, 2020 , ... Austin Oral Surgery – an oral and ... Dr. David Szalay, DDS, MD, has joined the practice. An accomplished oral and maxillofacial ... office, which is scheduled to open this fall. The new office is slated for ...
Breaking Medicine Technology: